Clincosm LogoSign in Get a demo

invasive breast carcinoma

Showing 51 - 70 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Adenocarcinoma, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Houston (Accelerated Partial Breast

Recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Accelerated Partial Breast Irradiation
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2021

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +23 more
  • Behavioral Intervention
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 16, 2021

Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v6 Trial in United States (External Beam

Active, not recruiting
Has Results
  • Ductal Breast Carcinoma In Situ
  • +7 more
  • External Beam Radiation Therapy
  • +5 more
  • Gilbert, Arizona
  • +6 more
Oct 21, 2021

Cancer Survivor, Invasive Breast Carcinoma Trial in Buffalo (Physical Activity, Questionnaire Administration, Repetitive

Completed
  • Cancer Survivor
  • Invasive Breast Carcinoma
  • Physical Activity
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 22, 2021

Ductal Breast Carcinoma In Situ, Early-Stage Breast Carcinoma, Invasive Breast Carcinoma Trial in United States (Laboratory

Recruiting
  • Ductal Breast Carcinoma In Situ
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Jacksonville, Florida
  • +15 more
Oct 12, 2021

Ductal Breast Carcinoma, Invasive Breast Carcinoma, Lobular Breast Carcinoma Trial in Canada, United States (Radiation Therapy,

Active, not recruiting
  • Ductal Breast Carcinoma
  • +8 more
  • Radiation Therapy
  • +4 more
  • Anchorage, Alaska
  • +858 more
Oct 1, 2021

Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma, Stage 0 Breast Cancer Trial in Salt Lake City (Hypofractionated

Recruiting
  • Ductal Breast Carcinoma In Situ
  • +8 more
  • Hypofractionated Radiation Therapy
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 27, 2021

Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (External Beam Radiation

Recruiting
  • Estrogen Receptor Negative
  • +11 more
  • External Beam Radiation Therapy
  • +4 more
  • Phoenix, Arizona
  • +7 more
Aug 4, 2021

Breast Adenocarcinoma, Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (Atezolizumab,

Active, not recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2021

Cancer Survivor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Chicago (drug, procedure, other)

Recruiting
  • Cancer Survivor
  • +2 more
  • Chicago, Illinois
    Northwestern University
Dec 2, 2020

Ductal Breast Carcinoma, Ductal Breast Carcinoma In Situ, Estrogen Receptor Negative Trial in Buffalo (Broccoli Sprout Extract,

Completed
  • Ductal Breast Carcinoma
  • +10 more
  • Broccoli Sprout Extract
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 29, 2019

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Unknown status
  • Anatomic Stage I Breast Cancer AJCC v8
  • +22 more
  • Decision Aid
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Sep 23, 2019

Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Akt Inhibitor GSK2141795,

Completed
Has Results
  • Estrogen Receptor Negative
  • +6 more
  • Akt Inhibitor GSK2141795
  • +2 more
  • Washington, District of Columbia
  • +7 more
Aug 27, 2019

Chemotherapy on Intestinal Bacteria in Newly Diagnosed Breast

Completed
  • Ductal Breast Carcinoma In Situ
  • +5 more
  • Cytology Specimen Collection Procedure
  • +2 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Jun 17, 2019

HER2/Neu Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma Trial in Houston (drug, other, biological)

Completed
  • HER2/Neu Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 17, 2019

Breast Cancer, Invasive Breast Carcinoma, Ductal Carcinoma In-situ Trial (Vitamin D3)

Withdrawn
  • Breast Cancer
  • +2 more
  • Vitamin D3
  • (no location specified)
Jan 16, 2019

HER2/Neu Negative, Invasive Breast Carcinoma, Postmenopausal Trial in Seattle (Anastrozole, Exemestane, Laboratory Biomarker

Withdrawn
  • HER2/Neu Negative
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 26, 2018

Estrogen Receptor Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma Trial in Saint Louis (Akt Inhibitor MK2206,

Completed
  • Estrogen Receptor Positive
  • +3 more
  • Akt Inhibitor MK2206
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 20, 2018

Invasive Breast Carcinoma, Primary Invasive Breast Cancer, Stage I Breast Cancer Trial in Boston (Capecitabine)

Terminated
  • Invasive Breast Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +2 more
Nov 9, 2015

Breast Cancer, Metastatic Breast Carcinoma, Invasive Breast Carcinoma Trial in Houston (Carboplatin, Cyclophosphamide, Thiotepa)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 28, 2013